Novartis: Lancet publishes pioneering study of Aimovig’s efficacy in episodic migraine patients

October 27, 2018
0

Novartis announced today that the full data from the LIBERTY study of Aimovig (erenumab) in episodic migraine patients who had tried and failed two to four prior preventive treatments have been published in the Lancet.

Source link

Early Antibiotics and Childhood Obesity: Do Future Risks Matter to Parents and Physicians?

How hibernators could help humans treat illness, conserve energy and get to Mars

You may also like

Optimal Muscle Selection for OnabotulinumtoxinA Injections in Poststroke Lower-Limb Spasticity: A Randomized Trial.

April 20, 2019
0

Related Articles Optimal Muscle

Read more

How does helping people affect your brain? Study shows neurobiological effects of providing support to others

April 20, 2019
0

neurosciencestuff: Providing “targeted”

Read more